Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events.
about
Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque.Rapid Progression of Coronary Atherosclerosis: A ReviewIntravascular optical imaging technology for investigating the coronary arteryMR imaging of the coronary vasculature: imaging the lumen, wall, and beyondNon-invasive imaging of atherosclerosisComparison of Acoustic Radiation Force Impulse Imaging Derived Carotid Plaque Stiffness With Spatially Registered MRI Determined Composition.Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levelsDetection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.Acoustic radiation force impulse imaging of vulnerable plaques: a finite element method parametric analysisMultimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice.Fluorescence lifetime in cardiovascular diagnostics.Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro.Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome.Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes.Raised soluble P-selectin moderately accelerates atherosclerotic plaque progressionThe role of latency period in quality management for free-breathing coronary wall MRI.Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaquesNanoimaging in cardiovascular diseases: Current state of the art.SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides.Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinicReal-Time Intravascular Ultrasound and Photoacoustic Imaging.Painting blood vessels and atherosclerotic plaques with an adhesive drug depotAssociation of apolipoprotein b/apolipoprotein A1 ratio and coronary artery stenosis and plaques detected by multi-detector computed tomography in healthy population.Nifedipine gastrointestinal therapeutic system: an overview of its antiatherosclerotic effects.Diagnosis and treatment of coronary vulnerable plaques.From vulnerable plaque to atherothrombosis.Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.Optical coherence tomography--near infrared spectroscopy system and catheter for intravascular imaging.Non-invasive assessment of vulnerable plaque.Comprehensive plaque assessment by coronary CT angiography.Role of biomechanical forces in the natural history of coronary atherosclerosis.Italian Chapter of the International Society of Cardiovascular Ultrasound expert consensus document on coronary computed tomography angiography: overview and new insights.Anti-inflammatory drugs as promising cardiovascular treatments.Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.Computational analysis of the effectiveness of blood flushing with saline injection from an intravascular diagnostic catheter.Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopesScanning Fiber Angioscopy: A Multimodal Intravascular Imaging Platform for Carotid Atherosclerosis.Imaging atherosclerotic plaque composition with intracoronary optical coherence tomography.Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.
P2860
Q26769824-45669357-DA30-4126-BCCA-BD2F5B9C6795Q26773002-4A9980A6-A4D2-40BD-B4BD-55EF85CEB8FBQ26852822-A5578162-41DB-48A6-B0B8-ADB752EC3BCEQ26991944-D08276B3-B9F1-4889-A3EE-84CDAD3D37DAQ26992143-06AB1408-6CAF-4521-BDF9-6322E86C0087Q30370980-BBD7A911-B328-4C12-8396-6FD08FE91D79Q30406302-916AE9C2-3AB5-4638-B368-8A59E7342C60Q30408017-1E7AACF3-6503-42DD-985A-BDBF18043FE6Q30444793-52B0DE97-F1D4-48FD-A597-63F9C30C5D6DQ33537691-751BE2E0-700F-42FC-B228-0EF934AD90CFQ33538215-67967E69-5C61-4D08-AEAE-66C256F81D0EQ33557193-A8B540AB-B114-4A69-8508-9763A0850E69Q33750461-1663420B-050D-4EFD-A8AA-2CD74964FE1CQ34982799-B41839D7-BA09-4ED9-9F6F-6A4B9EF3F86EQ35159990-54BF2562-41EB-4B66-A1C7-E8FE16417055Q35171696-8EA02882-0941-47ED-A7F4-03FE58233828Q35205502-6B0F5A1C-86BD-48D9-92D6-646282137089Q35262149-17258777-15FE-469D-9E0A-53BBCEA4F854Q35640852-6DD5458D-2AA8-420C-AB81-5B1DFB7D391CQ35796600-396D8C5D-A959-429D-86CD-D20CF7CA0CD5Q36095916-F4A1F5BA-3C0C-4850-892A-DC38B7E660EBQ36250606-02C8AF2C-151E-4BDF-857D-4BAE06948BDCQ36504186-720F2D8B-CBA7-477A-A781-13A0DF3B1BBCQ36841091-C9F798F7-A6EB-46D5-AD5E-E3D8934AA5C5Q36960568-E5EB035E-A01B-46F4-A4DF-A5875BC87EC9Q37076295-70BC1B8F-77E9-421A-9568-900E7E0A8F5BQ37138032-D2A56D08-511A-4BAE-B570-C4EEBF69A2A6Q37416508-1DE68AAF-F688-4230-97D2-9752C4D160BDQ37588594-BFF7C2BE-9682-45AA-8597-FB63235B2085Q38089812-B00FD3EB-7ACE-4F40-8CCA-0B3A36542326Q38206367-7A9F28BD-CF36-4687-9DE8-01E696170E4CQ38715461-E2F4EB70-3264-4970-B1EC-414E0C0C0B7AQ38859262-E336B5B1-54B0-4EB9-84E4-5693C04CA5A6Q39051784-808C594C-1767-4AAC-8986-29A3E700B887Q39434479-0E1E939E-00F7-4743-A209-6C9DB3049F6FQ40598582-6A310FF2-6DDC-4389-963F-79A4B25D7428Q41370572-1D9C75A9-391C-445B-972F-33B8E0DC51BBQ41655048-DA86F4D2-67B8-42B4-975B-3D06E2C1E209Q41831228-9627E4DD-FD13-4C56-B762-4853F58E4830Q41847179-292AEA09-BEC3-4218-978F-7A8B081A426C
P2860
Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Detection and treatment of vul ...... prevention of coronary events.
@ast
Detection and treatment of vul ...... prevention of coronary events.
@en
type
label
Detection and treatment of vul ...... prevention of coronary events.
@ast
Detection and treatment of vul ...... prevention of coronary events.
@en
prefLabel
Detection and treatment of vul ...... prevention of coronary events.
@ast
Detection and treatment of vul ...... prevention of coronary events.
@en
P2093
P1433
P1476
Detection and treatment of vul ...... prevention of coronary events.
@en
P2093
Fumiyuki Ishibashi
James E Muller
Sergio Waxman
P304
P356
10.1161/CIRCULATIONAHA.105.540013
P407
P577
2006-11-01T00:00:00Z